Thursday, 5 November 2026
Oral Wegovy approved, Victoria eases ADHD prescribing permits, NSW expands pharmacist prescribing
- 01
TGA approves oral Wegovy for chronic weight management
The TGA has approved daily oral semaglutide (Wegovy), Australia’s first oral GLP-1 formulation for weight management. The 1.5 mg, 4 mg, 9 mg and 25 mg tablets are indicated for chronic weight management and reducing major adverse cardiovascular event risk in eligible adults, consistent with injectable Wegovy’s indications. The tablets are not yet available locally, but manufacturer Novo Nordisk anticipates availability later this year, with pricing still undetermined. The TGA said oral or injectable Wegovy should not be used with other semaglutide-containing products or any other GLP-1 receptor agonist. RACGP President Dr Michael Wright said the oral formulation could broaden access for patients who had avoided injections, although it must be taken on an empty stomach because of limited absorption.
via RACGP newsGP · also covered by The Conversation — Health
- 02
Victoria removes permits for specified ADHD psychostimulant prescribing
Victorian GPs and nurse practitioners no longer need a Schedule 8 treatment permit to prescribe dexamphetamine, lisdexamfetamine or methylphenidate for ADHD in non-drug-dependent patients when a valid specialist ADHD treatment instruction is in place. Permits remain mandatory for patients who are drug dependent and when psychostimulants are prescribed for conditions other than ADHD, while prescribers must continue checking SafeScript each time they issue a controlled-substance prescription. Treatment instructions remain valid until any review date specified by the paediatrician, psychiatrist or ADHD practitioner, removing the previous two-year review requirement. From 1 December 2026, instructions must include the ADHD diagnosis and medication details, including name, dose, frequency and maximum dose. The Victorian Health Department said current permits could continue until expiry, while prescribers should cancel pending applications that are no longer required.
via RACGP newsGP
- 03
NSW recognises up to 250 more pharmacist prescribers
NSW will recognise prescribing qualifications for up to 250 additional pharmacists from tomorrow, expanding pharmacist-led treatment for several conditions. Equivalent qualifications from the University of Newcastle and the University of Technology Sydney will join the previously accepted James Cook University graduate certificate. Eligible pharmacists will be able to initiate oral contraception and prescribe for acute nausea and vomiting, rhinitis, GORD, mild acute musculoskeletal pain, and mild to moderate acne. Health Minister Ryan Park said the expansion would improve access to treatment for common conditions and free GP appointments for more complex care. The RACGP has asked Premier Chris Minns to disclose the Pharmacy Guild of Australia’s role in shaping the policy, citing patient safety concerns and joining four other medical peaks in calling for a freeze on further scope expansions.
- 04
NSW provider-data gaps delay digital interoperability work
Gaps in healthcare provider data after the first NSW Single Digital Patient Record go-live have delayed the state’s interoperability work. The affected information supports provider identification, referrals and secure messaging through NSW’s implementation of the National Health Services Directory. The Australian Digital Health Agency reported difficulties matching providers with national identifiers when names were not unique, with NSW developing a workaround and adding Australian Health Practitioner Regulation Agency data to its directory. Pathology uploads will include individual provider identifiers where possible until implementation is complete, while the broader national directory action remains on track. The report did not quantify affected records or pathology impacts, or give a timeframe for resolving the NSW issues.
- 05
Police investigate theft of NSW oral health provider data
Around 4GB of data relating to third-party health providers, mainly dentists, was stolen from the NSW Health Oral Health Fee For Service Scheme website, police believe. Officials declared the breach a major incident, with potentially sensitive personal identification information affected. NSW Health said no patient data had been compromised and no clinical services or other government agencies were affected. NSW Police launched a criminal investigation under Strike Force Civic and said the suspected perpetrators appeared to be outside Australia. eHealth NSW manually took the affected website offline after automated cybersecurity alerts detected the breach.
- 06
Notifier dissatisfaction rises despite fewer complaints about AHPRA
Against the recently reported 12-year high in tribunal referrals, the National Health Practitioner Ombudsman received 873 complaints in the latest financial year, down from 980 the previous year. Complaints about AHPRA’s handling of notifications fell about 3% to 492 but comprised 56% of all complaints, with doctor-related notification complaints unchanged at 336. Notifiers lodged 70% of notification-related complaints, and more than twice as many raised concerns about unfair processes, while complaints from practitioners who were the subject of notifications fell from 150 to 96. The five most common reasons involved notifiers’ concerns that AHPRA had closed their reports without further action. The ombudsman recommended framing assessments around risk, including future public risk, and AHPRA said it would consider the feedback in its planned review of notifications and compliance.
MDDR is a news digest for medical professionals. It is not medical advice and should not be relied on for clinical decision-making.